Trial intelligence / Profile preview

Optivate vs Haemate P in Von Willebrand Disease

NCT02250508Phase 2Completed

Sponsor
Bio Products Laboratory
Start
Dec 2004
Primary completion
Jun 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of factor viii + von Willebrand factor in von Willebrand disease (VWD), sponsored by Bio Products Laboratory. Started Dec 2004; status: completed.

02

Drugs

factor viii + von Willebrand factor
03

Conditions

von Willebrand disease (VWD)

Beyond the preview

Go deeper on NCT02250508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02250508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call